Currently Viewing:
Newsroom
Currently Reading
Muscle Relaxants During Anesthesia May Increase Risk of Postoperative Pulmonary Complications
October 20, 2018 – Alison Rodriguez
FDA Label Rule Change Gives Prescribers More Detail for Pregnant Women With Asthma
October 16, 2018 – David Bai, PharmD
FDA Inquiring If Some e-Cigarette Makers Are Selling Devices Without Approval
October 12, 2018 – Allison Inserro
FDA Approves Arikayce to Treat Certain Patients With Rare Lung Disease
October 11, 2018 – Alison Rodriguez
Tackling Antibiotic Prescribers' Behaviors for Respiratory Infections at the VA
October 05, 2018 – Allison Inserro
Study Finds Gaps in Medicaid Coverage Guidelines for Asthma Care
October 05, 2018 – Alison Rodriguez
What We're Reading: Demand for Antibiotics; FDA Inspects Juul; Fast Food Consumption
October 03, 2018 – AJMC Staff
Antibiotics May Be Feasible Alternative to Appendectomy in Acute Appendicitis
September 30, 2018 – Laura Joszt
Patients Taking Inhaled Steroids May Be at Greater Risk for NTM
September 28, 2018 – Alison Rodriguez

Muscle Relaxants During Anesthesia May Increase Risk of Postoperative Pulmonary Complications

Alison Rodriguez
Neuromuscular blocking agents, or muscle relaxants, are often used in surgery to prevent muscles from moving when a patient is unconscious. A recent study found that the use of neuromuscular blockers during general anesthesia is associated with an increased risk of postoperative pulmonary complications.
Neuromuscular blocking agents, or muscle relaxants, are often used in surgery to prevent muscles from moving when a patient is unconscious. A recent study found that the use of neuromuscular blockers during general anesthesia is associated with an increased risk of postoperative pulmonary complications.

The study, also referred to as POPULAR, involved the recruitment of patients from 211 hospitals in 28 European countries, who received general anesthesia for any in-hospital procedure except cardiac surgery. The researchers also collected patient characteristics, surgical and anesthetic details, and the chart review at discharge. Within 3 days of surgery, each patient included in the study underwent postoperative physical examination to assess for adverse pulmonary events.

“These drugs are particularly needed when operating on a patient’s chest or abdomen. They are also used to protect the vocal cords from injury when a tube is placed in the airway to allow artificial ventilation,” Manfred Blobner, MD, chair of the POPULAR steering committee, anesthesiologist at the Technical University of Munich’s Clinic for Anesthesiology and Intensive Care, said in a statement.

The primary study outcome was the incidence of postoperative pulmonary complications from the end of surgery up to postoperative day 28, according to the study. Logistic regression analyses were conducted and adjusted for surgical factors and patients’ preoperative physical status.

“It's important to note that neuromuscular blocking agents have made surgery considerably safer and more effective since their introduction several decades ago,” explained Blobner. “We have constantly refined both the drugs and the techniques used. Many operations would not be possible without them. Still, the results from POPULAR raise important questions.” 

Data from a total of 22,803 patients were collected between June 16, 2014 and April 29, 2015. The results revealed that the use of neuromuscular blocking agents was associated with an increased incidence of postoperative pulmonary complications in patients who had undergone general anesthesia. Furthermore, the use of neuromuscular monitoring and the administration of reversal agents were not associated with a decreased risk of postoperative pulmonary complications, according to the results.

The study emphasized that anesthetists must balance the potential benefits and risks of postoperative pulmonary complications before using neuromuscular blocking agents.

“Based on our results, we believe that patients undergoing minor surgical procedures that do not necessarily require neuromuscular blocking drugs might benefit from avoiding them,” concluded Blobner. “Using devices like laryngeal masks for anesthesia instead of tracheal tubes that go past the vocal cords could prove helpful, as well.”

Reference

Kirmeier E, Eriksson LI, Lewald H, et al. Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study. [published online September 14, 2018]. Lancet Respir Med. doi: 10.1016/S2213-2600(18)30294-7.

 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up